Glaxosmithkline Intellectual Property Holdings Limited

Company Name	Glaxosmithkline Intellectual Property Holdings Limited
Company Status	Active
Company Number	08283289
Category	Private Limited Company
Incorporation Date	6 November 2012(9 years, 6 months ago)

Business Activity

Section K	Financial and insurance activities
SIC 64209	Activities of other holding companies n.e.c.

Directors

Director Name	Mr Adam Walker
Date of Birth	November 1967 (Born 54 years ago)
Nationality	British
Status	Current
Appointed	28 March 2013(4 months, 3 weeks after company formation)
Appointment Duration	9 years, 2 months
Role	Accountant
Country of Residence	England
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Ms Kate Sophie Priestman
Date of Birth	November 1973 (Born 48 years ago)
Nationality	British
Status	Current
Appointed	09 December 2016(4 years, 1 month after company formation)
Appointment Duration	5 years, 5 months
Role	Strategy Professional
Country of Residence	United Kingdom
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Mr Jerome Charles Maurice Andries
Date of Birth	May 1969 (Born 53 years ago)
Nationality	French
Status	Current
Appointed	01 October 2017(4 years, 10 months after company formation)
Appointment Duration	4 years, 8 months
Role	Company Director
Country of Residence	England
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Mr James Russell Wheatcroft
Date of Birth	October 1967 (Born 54 years ago)
Nationality	British
Status	Current
Appointed	01 July 2019(6 years, 7 months after company formation)
Appointment Duration	2 years, 11 months
Role	Vp Controller R & D Director
Country of Residence	England
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Edinburgh Pharmaceutical Industries Limited (Corporation)
Status	Current
Appointed	06 November 2012(same day as company formation)
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Edinburgh Pharmaceutical Industries Limited (Corporation)
Status	Current
Appointed	06 November 2012(same day as company formation)
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Glaxo Group Limited (Corporation)
Status	Current
Appointed	06 November 2012(same day as company formation)
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Secretary Name	Edinburgh Pharmaceutical Industries Limited (Corporation)
Status	Current
Appointed	06 November 2012(same day as company formation)
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Secretary Name	Edinburgh Pharmaceutical Industries Limited (Corporation)
Status	Current
Appointed	06 November 2012(same day as company formation)
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Mr Paul Frederick Blackburn
Date of Birth	October 1954 (Born 67 years ago)
Nationality	British
Status	Resigned
Appointed	06 November 2012(same day as company formation)
Role	Financial Controller
Country of Residence	United Kingdom
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Mr Simon Paul Dingemans
Date of Birth	April 1963 (Born 59 years ago)
Nationality	British
Status	Resigned
Appointed	06 November 2012(same day as company formation)
Role	Company Director
Country of Residence	United Kingdom
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Mr Fraser Gemmell Macfarlane
Date of Birth	December 1970 (Born 51 years ago)
Nationality	British
Status	Resigned
Appointed	28 March 2013(4 months, 3 weeks after company formation)
Appointment Duration	3 years, 7 months (resigned 01 November 2016)
Role	Vp, Research & Development
Country of Residence	England
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Luigi Felice La Corte
Date of Birth	December 1969 (Born 52 years ago)
Nationality	Italian
Status	Resigned
Appointed	20 April 2015(2 years, 5 months after company formation)
Appointment Duration	2 years, 5 months (resigned 30 September 2017)
Role	Svp Finance, Pharma, R&D
Country of Residence	United Kingdom
Correspondence Address	Gsk 980 Great West Road Brentford Middlesex TW8 9GS

Contact

Website	gsk.com

Location

Registered Address	980 Great West Road Brentford Middlesex TW8 9GS
Region	London
Constituency	Brentford and Isleworth
County	Greater London
Ward	Brentford
Built Up Area	Greater London
Address Matches	Over 100 other UK companies use this postal address

Shareholders

101 at £1	Glaxosmithkline Llc 50.25% Ordinary A
100 at £1	Glaxo Group LTD 49.75% Ordinary B

Financials

Year	2014
Net Worth	£2,147,483,647
Current Liabilities	£1,940,045,000

Accounts

Latest Accounts	31 December 2020 (1 year, 4 months ago)
Next Accounts Due	30 September 2022 (4 months from now)
Accounts Category	Full
Accounts Year End	31 December

Returns

Latest Return	10 September 2021 (8 months, 3 weeks ago)
Next Return Due	24 September 2022 (3 months, 3 weeks from now)

Filing History

28 September 2021	Confirmation statement made on 10 September 2021 with no updates (3 pages)
27 September 2021	Full accounts made up to 31 December 2020 (21 pages)
9 October 2020	Full accounts made up to 31 December 2019 (20 pages)
24 September 2020	Confirmation statement made on 10 September 2020 with no updates (3 pages)
24 September 2019	Full accounts made up to 31 December 2018 (20 pages)
10 September 2019	Confirmation statement made on 10 September 2019 with no updates (3 pages)
3 September 2019	Appointment of Mr James Russell Wheatcroft as a director on 1 July 2019 (2 pages)
7 May 2019	Termination of appointment of Simon Paul Dingemans as a director on 1 May 2019 (1 page)
3 December 2018	Confirmation statement made on 6 November 2018 with no updates (3 pages)
6 October 2018	Full accounts made up to 31 December 2017 (17 pages)
5 March 2018	Notification of Glaxosmithkline Finance Plc as a person with significant control on 6 April 2016 (2 pages)
5 March 2018	Change of details for Glaxo Group Limited as a person with significant control on 6 April 2016 (2 pages)
30 January 2018	Director's details changed for Mr Jerome Charles Maurice Andries on 14 November 2017 (4 pages)
17 November 2017	Confirmation statement made on 6 November 2017 with updates (4 pages)
17 November 2017	Appointment of Mr Jerome Charles Maurice Andries as a director on 1 October 2017 (2 pages)
17 November 2017	Confirmation statement made on 6 November 2017 with updates (4 pages)
17 November 2017	Appointment of Mr Jerome Charles Maurice Andries as a director on 1 October 2017 (2 pages)
16 November 2017	Termination of appointment of Luigi Felice La Corte as a director on 30 September 2017 (1 page)
16 November 2017	Termination of appointment of Luigi Felice La Corte as a director on 30 September 2017 (1 page)
28 September 2017	Full accounts made up to 31 December 2016 (18 pages)
28 September 2017	Full accounts made up to 31 December 2016 (18 pages)
7 January 2017	Appointment of Kate Sophie Priestman as a director on 9 December 2016 (3 pages)
7 January 2017	Appointment of Kate Sophie Priestman as a director on 9 December 2016 (3 pages)
21 December 2016	Statement of capital following an allotment of shares on 16 December 2016 GBP 203 (3 pages)
21 December 2016	Statement of capital following an allotment of shares on 16 December 2016 GBP 203 (3 pages)
18 November 2016	Confirmation statement made on 6 November 2016 with updates (6 pages)
18 November 2016	Confirmation statement made on 6 November 2016 with updates (6 pages)
2 November 2016	Termination of appointment of Fraser Gemmell Macfarlane as a director on 1 November 2016 (1 page)
2 November 2016	Termination of appointment of Fraser Gemmell Macfarlane as a director on 1 November 2016 (1 page)
28 September 2016	Full accounts made up to 31 December 2015 (16 pages)
28 September 2016	Full accounts made up to 31 December 2015 (16 pages)
8 February 2016	Termination of appointment of Paul Frederick Blackburn as a director on 1 February 2016 (1 page)
8 February 2016	Termination of appointment of Paul Frederick Blackburn as a director on 1 February 2016 (1 page)
14 December 2015	Annual return made up to 6 November 2015 with a full list of shareholders Statement of capital on 2015-12-14 GBP 202 (8 pages)
14 December 2015	Annual return made up to 6 November 2015 with a full list of shareholders Statement of capital on 2015-12-14 GBP 202 (8 pages)
24 September 2015	Full accounts made up to 31 December 2014 (13 pages)
24 September 2015	Full accounts made up to 31 December 2014 (13 pages)
15 May 2015	Appointment of Luigi Felice La Corte as a director on 20 April 2015 (3 pages)
15 May 2015	Appointment of Luigi Felice La Corte as a director on 20 April 2015 (3 pages)
14 January 2015	Statement of capital following an allotment of shares on 17 December 2014 GBP 202 (3 pages)
14 January 2015	Statement of capital following an allotment of shares on 17 December 2014 GBP 202 (3 pages)
8 December 2014	Annual return made up to 6 November 2014 with a full list of shareholders Statement of capital on 2014-12-08 GBP 201 (7 pages)
8 December 2014	Annual return made up to 6 November 2014 with a full list of shareholders Statement of capital on 2014-12-08 GBP 201 (7 pages)
8 December 2014	Annual return made up to 6 November 2014 with a full list of shareholders Statement of capital on 2014-12-08 GBP 201 (7 pages)
16 August 2014	Full accounts made up to 31 December 2013 (11 pages)
16 August 2014	Full accounts made up to 31 December 2013 (11 pages)
2 July 2014	Previous accounting period extended from 30 November 2013 to 31 December 2013 (1 page)
2 July 2014	Previous accounting period extended from 30 November 2013 to 31 December 2013 (1 page)
16 January 2014	Statement of capital following an allotment of shares on 19 December 2013 GBP 201 (4 pages)
16 January 2014	Statement of capital following an allotment of shares on 19 December 2013 GBP 201 (4 pages)
19 December 2013	Annual return made up to 6 November 2013 with a full list of shareholders (7 pages)
19 December 2013	Annual return made up to 6 November 2013 with a full list of shareholders (7 pages)
19 December 2013	Annual return made up to 6 November 2013 with a full list of shareholders (7 pages)
17 May 2013	Appointment of Dr Fraser Gemmell Macfarlane as a director (3 pages)
17 May 2013	Appointment of Dr Fraser Gemmell Macfarlane as a director (3 pages)
1 May 2013	Appointment of Adam Walker as a director (3 pages)
1 May 2013	Appointment of Adam Walker as a director (3 pages)
31 January 2013	Statement of capital following an allotment of shares on 31 December 2012 GBP 200 (4 pages)
31 January 2013	Change of share class name or designation (2 pages)
31 January 2013	Particulars of variation of rights attached to shares (2 pages)
31 January 2013	Statement of capital following an allotment of shares on 31 December 2012 GBP 200 (4 pages)
31 January 2013	Change of share class name or designation (2 pages)
31 January 2013	Particulars of variation of rights attached to shares (2 pages)
11 January 2013	Memorandum and Articles of Association (33 pages)
11 January 2013	Resolutions RES01 ‐ Resolution of Memorandum and/or Articles of Association (3 pages)
11 January 2013	Memorandum and Articles of Association (33 pages)
11 January 2013	Resolutions RES01 ‐ Resolution of Memorandum and/or Articles of Association (3 pages)
6 November 2012	Incorporation (51 pages)
6 November 2012	Incorporation (51 pages)

Glaxosmithkline Intellectual Property Holdings Limited

Business Activity

Directors

Contact

Location

Shareholders

Financials

Accounts

Returns

Filing History

Contact Companies London